The National Health Care Fraud Takedown has resulted in criminal charges against 455 defendants, including 90 doctors and other licensed medical professionals, for their alleged involvement in health care fraud schemes worth more than $6.5 billion. Announced by the U.S. Department of Justice (DOJ), the nationwide enforcement operation also targeted opioid-related crimes and fraud schemes that authorities say caused significant patient harm, including deaths.

The 2026 operation marks the largest coordinated action of its kind, involving cases across 56 federal districts, 45 states and territories, and participation from all 50 Medicaid Fraud Control Units.

National Health Care Fraud Takedown Reaches Record Scale

According to the DOJ, the enforcement action reflects an expanded effort by federal, state, and international authorities to combat fraud within government-funded healthcare programs.

Authorities announced charges against hundreds of individuals connected to Medicare fraud, Medicaid fraud, telemedicine fraud, illegal kickback schemes, and unlawful opioid distribution. Investigators also seized more than $182 million in assets, including cash, luxury vehicles, jewelry, and real estate.

In parallel, the Centers for Medicare and Medicaid Services suspended 1,079 providers and revoked billing privileges for 1,403 providers. Federal agencies also secured more than $73 million in civil monetary settlements and initiated thousands of administrative enforcement actions.

Billions in Fraudulent Wound Care Claims Uncovered

A significant portion of the cases announced during the National Health Care Fraud Takedown involved fraudulent billing for amniotic wound allografts.

The DOJ charged 11 defendants, including company executives and medical professionals, in connection with schemes that generated billions of dollars in Medicare claims. In one Arizona case, authorities alleged that a company executive participated in an illegal kickback operation tied to allograft products that generated more than $4 billion in Medicare billings and over $2 billion in payments.

Investigators claim marketers and providers received substantial kickbacks while applying medically unnecessary treatments to patients, including hospice patients. Prosecutors allege the products were sold with markups as high as 2,000%.

In a separate Texas case, a nurse practitioner was charged in connection with a $906 million fraud scheme involving medically unnecessary allograft applications. Authorities seized more than $30 million in assets linked to the investigation.

Data Analytics Drive Health Care Fraud Investigations

Federal officials highlighted the growing role of advanced analytics in identifying fraudulent activity.

The DOJ’s Data Fusion Center, established to combine financial intelligence and healthcare data analysis, played a key role in several investigations announced during the takedown. One investigation led to charges against a defendant accused of submitting claims for behavioral health services that allegedly exceeded what providers could physically deliver, while diverting millions of dollars toward luxury purchases and investments.

Officials said data analysis also helped uncover hospice fraud, fraudulent Medicaid billing schemes, and Medicare claims tied to services that were never provided.

CMS Administrator Dr. Mehmet Oz stated that the agency is increasingly relying on advanced analytics to identify suspicious payment activity and stop fraudulent claims before taxpayer funds are released.

Medicaid Fraud and International Arrests Highlight Global Reach

The 2026 operation also recorded the largest number of Medicaid fraud defendants and losses charged in Department history. Authorities charged 295 defendants linked to more than $518 million in alleged fraudulent Medicaid claims.

Cases announced included schemes involving adult day care services, behavioral health programs, and fraudulent claims targeting vulnerable populations, including homeless individuals and people struggling with substance abuse.

The takedown also demonstrated unprecedented international cooperation. Authorities secured the apprehension and return of several suspects located overseas, including individuals linked to multibillion-dollar fraud operations.

Among those apprehended were suspects connected to a previously charged $10.6 billion fraud scheme and a separate $3.7 billion medical equipment fraud case.

Opioid Fraud and Patient Harm Cases Included

The DOJ health care fraud crackdown also targeted illegal opioid distribution. Authorities charged 36 defendants, including 28 licensed medical professionals, for allegedly diverting prescription opioids and controlled substances.

Several cases involved allegations that prescriptions were issued without proper patient interaction, while others focused on large-scale drug distribution networks.

Officials emphasized that the enforcement effort was aimed not only at protecting taxpayer funds but also at preventing patient harm caused by fraudulent medical practices.

The Department of Justice noted that all charges announced as part of the National Health Care Fraud Takedown remain allegations, and all defendants are presumed innocent unless proven guilty in court.